SCHEDULE: Alkeon Capital Discloses 5.7% Stake in Hinge Health

Alkeon Capital Management LLC and Panayotis D. Sparaggis have disclosed a 5.7% beneficial ownership stake in Hinge Health, Inc.'s Class A Common Stock.

Summary

• Alkeon Capital Management LLC and Panayotis D. Sparaggis reported beneficial ownership of 1,591,104 shares of Hinge Health, Inc.'s Class A Common Stock.
• This represents a 5.7% stake in the Class A Common Stock of Hinge Health, Inc.
• The reported shares include 1,215,093 shares of Class A Common Stock issuable upon conversion of Class B Common Stock.
• The percentage is calculated based on an aggregate of 26,799,441 shares of Class A Common Stock outstanding as reported in the Company's Prospectus and Current Report on Form 8-K filed on May 23, 2025.
• The filing is a Schedule 13G, indicating a passive investment purpose by an investment adviser and an individual.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or outlook. It indicates a significant institutional investment.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investment in Hinge Health, a company likely operating in the digital health or musculoskeletal care technology sector. Such disclosures by prominent investment managers like Alkeon Capital can signal confidence in the company's long-term prospects or strategic direction within the broader healthcare technology industry.

Stakeholder Impact

• Shareholders: Disclosure of a significant institutional investor may influence market perception and potentially share price due to increased institutional interest.

Key Dates

Keywords

Hinge Health, Alkeon Capital Management, Panayotis D. Sparaggis, Beneficial Ownership, Schedule 13G, Class A Common Stock, Investment Management, Healthcare Technology